Type d'article
Etat
Reliure
Particularités
Pays
Evaluation du vendeur
Edité par Oxford University Press 1899-12-30, 1899
ISBN 10 : 0199734313ISBN 13 : 9780199734313
Vendeur : Bellwetherbooks, McKeesport, PA, Etats-Unis
Livre
Etat : Fine. 0199734313 LIKE NEW/UNREAD!!! Text is Clean and Unmarked!!! Has a small black line on the bottom/exterior edge of pages. Tracking is not available for orders shipped outside of the United States. **Heavier books will require additional postage for International**.
Edité par Oxford University Press, USA, 2011
ISBN 10 : 0199734313ISBN 13 : 9780199734313
Vendeur : Powell's Bookstores Chicago, ABAA, Chicago, IL, Etats-Unis
Livre
Etat : Used - Like New. 2011. Paperback. Fine.
Edité par Oxford University Press, USA, 2011
ISBN 10 : 0199734313ISBN 13 : 9780199734313
Vendeur : Ergodebooks, Houston, TX, Etats-Unis
Livre
Paperback. Etat : New.
Edité par Oxford University Press, 2011
ISBN 10 : 0199734313ISBN 13 : 9780199734313
Vendeur : Irish Booksellers, Portland, ME, Etats-Unis
Livre
Etat : Good. SHIPS FROM USA. Used books have different signs of use and do not include supplemental materials such as CDs, Dvds, Access Codes, charts or any other extra material. All used books might have various degrees of writing, highliting and wear and tear and possibly be an ex-library with the usual stickers and stamps. Dust Jackets are not guaranteed and when still present, they will have various degrees of tear and damage. All images are Stock Photos, not of the actual item. book.
Edité par Oxford University Press, USA, 2011
ISBN 10 : 0199734313ISBN 13 : 9780199734313
Vendeur : Ergodebooks, Houston, TX, Etats-Unis
Livre
Paperback. Etat : Good.
Edité par American Diabetes Association, 2016
ISBN 10 : 158040619XISBN 13 : 9781580406192
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Soft Cover. Etat : new.
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : INDOO, Avenel, NJ, Etats-Unis
Livre
Etat : As New. Unread copy in mint condition.
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : INDOO, Avenel, NJ, Etats-Unis
Livre
Etat : New. Brand New.
Edité par American Diabetes Association, 2016
ISBN 10 : 158040619XISBN 13 : 9781580406192
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Livre Edition originale
Etat : New. Num Pages: 144 pages, illustrations. BIC Classification: MJGD; MMG. Category: (G) General (US: Trade). Dimension: 229 x 152 x 10. Weight in Grams: 199. . 2016. 1st Edition. Paperback. . . . .
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Soft Cover. Etat : new.
Edité par Amer Diabetes Assn, 2016
ISBN 10 : 158040619XISBN 13 : 9781580406192
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Livre
Paperback. Etat : Brand New. 1st edition. 133 pages. 9.00x5.25x0.25 inches. In Stock.
Edité par American Diabetes Association, 2016
ISBN 10 : 158040619XISBN 13 : 9781580406192
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
Livre
Etat : New. Num Pages: 144 pages, illustrations. BIC Classification: MJGD; MMG. Category: (G) General (US: Trade). Dimension: 229 x 152 x 10. Weight in Grams: 199. . 2016. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GF Books, Inc., Hawthorne, CA, Etats-Unis
Livre
Etat : Good. Book is in Used-Good condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear and contain limited notes and highlighting.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GF Books, Inc., Hawthorne, CA, Etats-Unis
Livre
Etat : Fine. Book is in Used-LikeNew condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GF Books, Inc., Hawthorne, CA, Etats-Unis
Livre
Etat : Very Good. Book is in Used-VeryGood condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear and contain very limited notes and highlighting.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
Livre
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre
Etat : New. In.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Brook Bookstore, Milano, MI, Italie
Livre
Etat : new.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GF Books, Inc., Hawthorne, CA, Etats-Unis
Livre
Etat : New. Book is in NEW condition.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Book Deals, Tucson, AZ, Etats-Unis
Livre
Etat : New. New! This book is in the same immaculate condition as when it was published.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Livre
Paperback / softback. Etat : New. New copy - Usually dispatched within 4 working days.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Byrd Books, Austin, TX, Etats-Unis
Livre
Paperback. Etat : very good. In Used Condition.
Edité par American Diabetes Association, Alexandria, 2016
ISBN 10 : 158040619XISBN 13 : 9781580406192
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Livre
Paperback. Etat : new. Paperback. Over 29 million Americans have diabetes. Of those millions of people, the majority take at least one medication to treat their diabetes, but also take additional medications or supplements for other conditions. With this complex array of medications across such a broad and diverse population, potential contraindications are a real possibility. Diabetes Risks from Prescription and Nonprescription Drugs surveys the medication landscape and provides brief yet illuminating information on the potential effects any medication may have on people currently treating diabetes or whether any particular medication may increase the risk that someone will develop diabetes.Designed with the busy clinician in mind, Dr. Dagogo-Jack provides succinct descriptions of the drugs that may interact with diabetes medications or increase the risk of developing diabetes. He includes information from the latest clinical studies and the most recent literature to present a comprehensive, authoritative text on an elusive and troubling clinical conundrum. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GoldBooks, Denver, CO, Etats-Unis
Livre
Paperback. Etat : very good. Very Good Copy. Customer Service Guaranteed.
Edité par Amer Diabetes Assn, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Livre
Paperback. Etat : Brand New. 1st edition. 210 pages. 8.75x5.75x0.50 inches. In Stock.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Livre
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : GoldenWavesOfBooks, Fayetteville, TX, Etats-Unis
Livre
Paperback. Etat : new. New. Fast Shipping and good customer service.
Edité par American Diabetes Association, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : Front Cover Books, Denver, CO, Etats-Unis
Livre
Etat : new.
Edité par American Diabetes Association, Alexandria, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Livre
Paperback. Etat : new. Paperback. Prediabetes affects nearly 90 million U.S. adults and more than 374 million people worldwide. But what exactly is prediabetes, and how should it be treated?Individuals with prediabetes have a high risk of progressing to type 2 diabetes. Diabetes currently affects approximately 30 million adults in the U.S. and 463 million people worldwide, and type 2 diabetes represents 90-95% of the diabetes burden. Individuals with prediabetes also face increased risks of developing several complications including heart disease. Intervention at the prediabetes stage can help prevent progression to type 2 diabetes, and even lead to remission of prediabetes and a return to normal blood glucose regulation (NGR). However, a deeper understanding of the pathobiology of prediabetes is critical to the discovery and delivery of programs for preventing of diabetes.Focusing on prediabetes is compelling: Understanding the numerous risk factors that trigger the initial escape from NGR toward prediabetes provides critical information that enables the precise and timely targeting of preventive interventions to at-risk persons.This book is for clinicians, researchers, public health practitioners and policy makers. It begins with an overview of the demographic, anthropometric, biobehavioral and biochemical factors that drive the transition from normal blood glucose to prediabetes. Emerging knowledge from the fields of genomics, transcriptomics, microRNAs, metabolomics and microbiomics is incorporated into a comprehensive treatise on the pathobiology of prediabetes.Next, the focus shifts to evidence-based management of prediabetes and prevention of type 2 diabetes. Prediabetes seldom remits spontaneously. Lifestyle modification and certain medications can prevent progression from prediabetes to type 2 diabetes and may even induce remission of prediabetes in some people. Landmark diabetes prevention trials are discussed through the prism of their successful translatability in communities around the world. Emphasis is placed on practical adaptations that would enable cost-effective community diabetes prevention initiatives.Interventions utilizing lifestyle modification are prioritized over medications, but novel approaches (including cyclical medication strategy, designer nutraceuticals and metabolic surgery) are also discussed. Current lifestyle intervention protocols have been more effective at preventing progression from prediabetes to type 2 diabetes than they have been at restoring NGR. This book makes the case that reversal of prediabetes and restoration of normal blood glucose levels carries numerous benefits and ought to be the primary goal of intervention in people with prediabetes. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Edité par American Diabetes Association, Alexandria, 2021
ISBN 10 : 1580407625ISBN 13 : 9781580407625
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Livre
Paperback. Etat : new. Paperback. Prediabetes affects nearly 90 million U.S. adults and more than 374 million people worldwide. But what exactly is prediabetes, and how should it be treated?Individuals with prediabetes have a high risk of progressing to type 2 diabetes. Diabetes currently affects approximately 30 million adults in the U.S. and 463 million people worldwide, and type 2 diabetes represents 90-95% of the diabetes burden. Individuals with prediabetes also face increased risks of developing several complications including heart disease. Intervention at the prediabetes stage can help prevent progression to type 2 diabetes, and even lead to remission of prediabetes and a return to normal blood glucose regulation (NGR). However, a deeper understanding of the pathobiology of prediabetes is critical to the discovery and delivery of programs for preventing of diabetes.Focusing on prediabetes is compelling: Understanding the numerous risk factors that trigger the initial escape from NGR toward prediabetes provides critical information that enables the precise and timely targeting of preventive interventions to at-risk persons.This book is for clinicians, researchers, public health practitioners and policy makers. It begins with an overview of the demographic, anthropometric, biobehavioral and biochemical factors that drive the transition from normal blood glucose to prediabetes. Emerging knowledge from the fields of genomics, transcriptomics, microRNAs, metabolomics and microbiomics is incorporated into a comprehensive treatise on the pathobiology of prediabetes.Next, the focus shifts to evidence-based management of prediabetes and prevention of type 2 diabetes. Prediabetes seldom remits spontaneously. Lifestyle modification and certain medications can prevent progression from prediabetes to type 2 diabetes and may even induce remission of prediabetes in some people. Landmark diabetes prevention trials are discussed through the prism of their successful translatability in communities around the world. Emphasis is placed on practical adaptations that would enable cost-effective community diabetes prevention initiatives.Interventions utilizing lifestyle modification are prioritized over medications, but novel approaches (including cyclical medication strategy, designer nutraceuticals and metabolic surgery) are also discussed. Current lifestyle intervention protocols have been more effective at preventing progression from prediabetes to type 2 diabetes than they have been at restoring NGR. This book makes the case that reversal of prediabetes and restoration of normal blood glucose levels carries numerous benefits and ought to be the primary goal of intervention in people with prediabetes. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.